Heartflow Q4 revenue $49.1M (+40% YoY); FY2025 revenue $176M; guides FY2026 revenue $218-222M

Heartflow, Inc.

Q4 revenue $49.1M (+40% YoY); gross margin 79.5%; net loss $24.4M ($0.29/share).
Full year 2025 revenue $176M (+40% YoY); net loss $116.8M ($3.17/share).
FY2026 guidance: revenue $218M-$222M (24%-26% growth); non-GAAP gross margin 80-81%.
U.S. installed base 1,465 accounts; Plaque installed base 489; Aetna coverage brings Plaque covered lives to ~75%.
Warrants fully net exercised; no future noncash warrant revaluation charges; cash $280.2M.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Heartflow, Inc. reported the quarter and full year ended December 31, 2025 results: revenue $49.1 million, net income $(0.29) net loss per share.

Period: the quarter and full year ended December 31, 2025
Revenue: $49.1 million
Net income: $(0.29) net loss per share
Result: reported results

Exact text from the filing

artery disease (CAD), today reported financial results for the fourth quarter and full year ended Dec ember 3 1 , 2025. Fourth Quarter 2025 Highlights " Total revenue of $49.1 million, a 40% increase year-over-year " Gross margin of 79.5%, non-GAAP gross margin of 79.9% " Net operating loss of $17. 8 million, non-GAAP net operating loss of $12.5 million " U.S.

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

Heartflow, Inc. filing history →

Source: SEC EDGAR

accession 0001464521-26-000040

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.